JP2020527569A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527569A5 JP2020527569A5 JP2020502226A JP2020502226A JP2020527569A5 JP 2020527569 A5 JP2020527569 A5 JP 2020527569A5 JP 2020502226 A JP2020502226 A JP 2020502226A JP 2020502226 A JP2020502226 A JP 2020502226A JP 2020527569 A5 JP2020527569 A5 JP 2020527569A5
- Authority
- JP
- Japan
- Prior art keywords
- quercetin
- therapeutic agent
- subject
- agent according
- glucopyranosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023061067A JP2023093533A (ja) | 2017-07-17 | 2023-04-05 | 放射線または放射線療法によって引き起こされた放射線誘発性バイスタンダ効果を防止および治療するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533272P | 2017-07-17 | 2017-07-17 | |
| US62/533,272 | 2017-07-17 | ||
| PCT/US2018/042569 WO2019018451A2 (en) | 2017-07-17 | 2018-07-17 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED PROXIMITY EFFECTS CAUSED BY RADIATION OR RADIATION THERAPY |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061067A Division JP2023093533A (ja) | 2017-07-17 | 2023-04-05 | 放射線または放射線療法によって引き起こされた放射線誘発性バイスタンダ効果を防止および治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527569A JP2020527569A (ja) | 2020-09-10 |
| JP2020527569A5 true JP2020527569A5 (enExample) | 2021-08-26 |
| JP7598137B2 JP7598137B2 (ja) | 2024-12-11 |
Family
ID=65015329
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502226A Active JP7598137B2 (ja) | 2017-07-17 | 2018-07-17 | 放射線または放射線療法によって引き起こされた放射線誘発性バイスタンダ効果を防止および治療するための組成物および方法 |
| JP2023061067A Pending JP2023093533A (ja) | 2017-07-17 | 2023-04-05 | 放射線または放射線療法によって引き起こされた放射線誘発性バイスタンダ効果を防止および治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061067A Pending JP2023093533A (ja) | 2017-07-17 | 2023-04-05 | 放射線または放射線療法によって引き起こされた放射線誘発性バイスタンダ効果を防止および治療するための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11452709B2 (enExample) |
| EP (1) | EP3655015B1 (enExample) |
| JP (2) | JP7598137B2 (enExample) |
| CN (1) | CN111447940A (enExample) |
| CA (1) | CA3069701A1 (enExample) |
| WO (1) | WO2019018451A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3655015B1 (en) | 2017-07-17 | 2024-02-21 | The Regents of the University of Colorado | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy |
| CN112553286A (zh) * | 2020-11-05 | 2021-03-26 | 北京大学深圳医院 | 自杀基因/前药系统疗效的评价方法和药物筛选方法 |
| KR102817623B1 (ko) * | 2021-05-14 | 2025-06-10 | 한국원자력의학원 | 방사선 치료 예후 예측용 또는 방사선 저항성 암 진단용 바이오마커 조성물 |
| CN114392255A (zh) * | 2021-11-10 | 2022-04-26 | 甘肃中医药大学 | 乌拉尔醇的新应用 |
| CN114150054B (zh) * | 2021-12-03 | 2022-08-02 | 中国科学院近代物理研究所 | 检测或评估电离辐射损伤或暴露的试剂及其所用tRNA衍生片段 |
| CN114350787B (zh) * | 2022-01-12 | 2023-06-30 | 中国人民解放军军事科学院军事医学研究院 | 一种ATE1的RNA m6A修饰作为γ射线辐射标志物的应用 |
| CN119185555B (zh) * | 2024-11-27 | 2025-04-04 | 浙江大学 | 一种用于干预捻转血矛线虫群体性别比例的siRNA及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
| ATE115999T1 (de) | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5244805A (en) | 1989-05-17 | 1993-09-14 | University Of Georgia Research Foundation, Inc. | Baculovirus expression vectors |
| US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5723750A (en) | 1995-01-12 | 1998-03-03 | Vanderbilt University | Transgenic plants expressing disassembly deficient viral coat proteins |
| US6278039B1 (en) | 1997-05-28 | 2001-08-21 | Axys Pharmaceuticals, Inc. | C. elegans deletion mutants |
| US6251588B1 (en) | 1998-02-10 | 2001-06-26 | Agilent Technologies, Inc. | Method for evaluating oligonucleotide probe sequences |
| US6110462A (en) | 1999-03-03 | 2000-08-29 | The Scripps Research Institute | Enzymatic DNA molecules that contain modified nucleotides |
| JP5984324B2 (ja) * | 2005-12-01 | 2016-09-06 | メディカル プログノシス インスティテュート エー／エス | 治療反応のバイオマーカーを同定するための方法および装置、ならびに治療効果を推定するためのその使用 |
| WO2008106463A1 (en) | 2007-02-26 | 2008-09-04 | The Board Of Trustees Of The Univerity Of Illinois | Phenylalanine for plant protection against uv radiation |
| EA201001262A1 (ru) * | 2008-02-07 | 2011-04-29 | Вайробей, Инк. | Ингибиторы катепсина в |
| IT1393841B1 (it) | 2009-04-30 | 2012-05-11 | Giuliani Spa | Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi |
| DE102010025970A1 (de) * | 2010-07-02 | 2012-01-05 | Papst Licensing Gmbh & Co. Kg | Verfahren zur Bestimmung von Proteasen und ihren Proformen |
| CN101907614B (zh) * | 2010-07-26 | 2012-05-23 | 中国科学院长春应用化学研究所 | 超高效液相色谱和质谱联用筛选组织蛋白酶b抑制剂的方法 |
| EP3655015B1 (en) | 2017-07-17 | 2024-02-21 | The Regents of the University of Colorado | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy |
-
2018
- 2018-07-17 EP EP18835933.5A patent/EP3655015B1/en active Active
- 2018-07-17 CN CN201880060319.XA patent/CN111447940A/zh active Pending
- 2018-07-17 JP JP2020502226A patent/JP7598137B2/ja active Active
- 2018-07-17 US US16/632,046 patent/US11452709B2/en active Active
- 2018-07-17 WO PCT/US2018/042569 patent/WO2019018451A2/en not_active Ceased
- 2018-07-17 CA CA3069701A patent/CA3069701A1/en active Pending
-
2022
- 2022-06-29 US US17/852,475 patent/US12447142B2/en active Active
-
2023
- 2023-04-05 JP JP2023061067A patent/JP2023093533A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527569A5 (enExample) | ||
| JP2018126141A5 (enExample) | ||
| US20110250297A1 (en) | Treatment of Hyperproliferative Disorders Using Cardiac Glycosides | |
| US20100279978A1 (en) | Methods of reducing the severity of mucositis | |
| US20130274219A1 (en) | Methods for treating non-small cell lung cancer using 5-azacytidine | |
| US11185523B2 (en) | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer | |
| US20030236217A1 (en) | Treatment of mucositis | |
| US20200108089A1 (en) | Gemcitabine Derivatives for Cancer Therapy | |
| JP2010511039A5 (enExample) | ||
| CN101402667B (zh) | 糖基化修饰的一氧化氮供体型齐墩果酸类化合物、其制备方法及用途 | |
| CN107198777A (zh) | 用于治疗癌症的含有聚核苷酸的药物组合物 | |
| Kaufman-Szymczyk et al. | The effects of clofarabine in ALL inhibition through DNA methylation regulation | |
| US20060165656A1 (en) | Medicinal preparation having chemotherapeutic encapsulated therein | |
| THOMAS et al. | Primary pulmonary rhabdomyosarcoma in childhood | |
| CN101653607B (zh) | 含有肝细胞生长因子受体抑制剂和丝裂原细胞外激酶抑制剂的药物组合物及其用途 | |
| CA2606727A1 (en) | Lipid a analogs for treating oral and gastrointestinal mucositis | |
| WO2023144815A1 (en) | Compositions and methods for covid-19 treatment | |
| Pollak et al. | Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interaction | |
| Chu et al. | Chemotherapy-induced recall dermatitis on a previously scalded wound in a patient with acute myeloid leukaemia | |
| Miranda | Blockade of P2 Nucleotide Receptors After Spinal Cord Injury Reduced the Gliotic Response and Spared Tissue | |
| Kapse et al. | A review on the 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease | |
| US8586561B2 (en) | Anti-tumor agent comprising cytidine derivative and carboplatin | |
| EP2415775B1 (en) | Agent for inhibiting thickening of peritoneal membrane | |
| CN120695191A (zh) | Fr054在逆转胶质母细胞瘤替莫唑胺耐药中的应用 | |
| EP4489763A1 (en) | Inhibitors of eif4a |